General MedicationsTOPICALStandard
TWYNEO
BENZOYL PEROXIDE; TRETINOIN
Standard Dose
3%;0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TWYNEO is listed in Drugs@FDA under application 214902 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; TRETINOIN Form and strength CREAM;TOPICAL - 3%;0.1% Sponsor MAYNE PHARMA Submission history Latest submission status date: 2021-07-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview TWYNEO is listed in Drugs@FDA under application 214902 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BENZOYL PEROXIDE; TRETINOIN Form and strength CREAM;TOPICAL - 3%;0.1% Sponsor MAYNE PHARMA Submission history Latest submission status date: 2021-07-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.